Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,269Revenue $M443Net Margin (%)58.0Z-Score4.6
Enterprise Value $M1,478EPS $1.7Operating Margin %92.5F-Score3
P/E(ttm))4.1Cash Flow Per Share $1.5Pre-tax Margin (%)89.9Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsN
Price/Sales2.35-y EBITDA Growth Rate %20.0Current Ratio1.3Lower Leverage y-yY
Price/Cash Flow5.0y-y EBITDA Growth Rate %21.7ROA % (ttm)44.1Higher Current Ratio y-yN
Dividend Yield %7.6Insider Buy (3m)1ROE % (ttm)154Less Shares Outstanding y-yN
Payout Ratio %30.0Shares Outstanding M161ROI % (ttm)162Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2014-09-30 Reduce-0.09%$7.51 - $10.26
($9.3)
$ 7.9-15%Reduce -96.71%25,997
PDLIJohn Hussman 2014-06-30 Sold Out -0.68%$8 - $9.85
($8.9)
$ 7.9-11%Sold Out0
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 7.9-11%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 7.9-8%Reduce -50.19%1,665,543
PDLIJohn Hussman 2013-12-31 Reduce-0.49%$7.59 - $10.1
($8.43)
$ 7.9-6%Reduce -50.99%1,087,000
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 7.9-2%Add 24.84%2,890,564
PDLIJohn Hussman 2013-09-30 Reduce-0.21%$7.72 - $8.44
($8.04)
$ 7.9-2%Reduce -21.04%2,218,000
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 7.912%Add 23.5%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 7.92%Add 561.89%1,729,133
PDLIJohn Hussman 2012-12-31 Add0.09%$7.09 - $8.37
($7.75)
$ 7.92%Add 20.19%3,012,000
PDLIJohn Hussman 2012-09-30 Add0.29%$6.59 - $7.73
($7.11)
$ 7.911%Add 176.91%2,506,000
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 7.933%Add 33.54%270,346
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 7.933%Sold Out0
PDLIJoel Greenblatt 2011-12-31 Add0.04%$5.35 - $6.4
($5.97)
$ 7.932%Add 31.29%202,444
PDLISeth Klarman 2011-12-31 Reduce-1.4%$5.35 - $6.4
($5.97)
$ 7.932%Reduce -48.84%8,000,000
PDLIGeorge Soros 2011-12-31 Sold Out -0.001%$5.35 - $6.4
($5.97)
$ 7.932%Sold Out0
PDLISeth Klarman 2011-09-30 Add1.17%$5.47 - $6.39
($5.91)
$ 7.934%Add 68.81%15,636,000
PDLIJohn Hussman 2011-09-30 Buy 0.08%$5.47 - $6.39
($5.91)
$ 7.934%New holding, 905000 sh.905,000
PDLIJoel Greenblatt 2011-09-30 Add0.04%$5.47 - $6.39
($5.91)
$ 7.934%Add 41.81%154,201
PDLIGeorge Soros 2011-09-30 Buy $5.47 - $6.39
($5.91)
$ 7.934%New holding, 10000 sh.10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PDLI Jean-Marie Eveillard 2014-09-302,80000
PDLI Joel Greenblatt 2014-09-3025,9970.020-96.71%
Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-5.82view
Lindell Jody SDirector 2011-03-15Buy374$5.3342.78view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.7133.27view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.1823.14view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-8.64view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-1.93view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.383.12view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.383.12view
KLEIN JOSEPH IIIDirector 2008-05-20Buy500$9.5-19.89view
KLEIN JOSEPH IIIDirector 2008-05-06Buy500$9.6-20.73view

Press Releases about PDLI :

    Quarterly/Annual Reports about PDLI:

    News about PDLI:

    Articles On GuruFocus.com
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Oct 17 2014 
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma Inc Oct 15 2014 
    Hot Picks with High Yields Jul 23 2013 
    My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
    comment on PDLI May 12 2013 
    My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
    FV 22 MSN 10 Apr 19 2013 
    68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
    20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 
    comment on PDLI Nov 13 2012 


    More From Other Websites
    PDL BioPharma Completes Regular Quarterly Dividend Payment Dec 15 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 15 2014
    PDL BioPharma Completes Regular Quarterly Dividend Payment Dec 15 2014
    PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties Dec 11 2014
    PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million Dec 10 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Dec 10 2014
    PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million Dec 10 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Dec 09 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Dec 08 2014
    PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes Dec 04 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 04 2014
    PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes Dec 04 2014
    PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics Dec 01 2014
    PDL BIOPHARMA, INC. Financials Nov 19 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 19 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other... Nov 18 2014
    PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics Nov 18 2014
    PDL BIOPHARMA 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney... Nov 14 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in PDL... Nov 14 2014
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against PDL BioPharma... Nov 14 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK